December 12, 2025 a 07:43 pm
ZBH: Fundamental Ratio Analysis - Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. operates in the innovative medical device sector, offering an array of orthopedic and dental products worldwide. The company's strong R&D capabilities position it well within the competitive healthcare industry. With a history dating back to 1927, Zimmer Biomet has a well-established market presence and serves a diverse clientele of medical professionals worldwide.
Fundamental Rating
The current fundamentals for Zimmer Biomet indicate moderate growth potential, balancing existing risks and opportunities.
| Category | Score | Score Visual |
|---|---|---|
| Discounted Cash Flow (DCF) | 5 | |
| Return on Equity (ROE) | 3 | |
| Return on Assets (ROA) | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings (P/E) | 2 | |
| Price to Book (P/B) | 4 |
Historical Rating
The historical ratings provide a snapshot of the company's fundamental progression over time.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-12-12 | 3 | 5 | 3 | 4 | 1 | 2 | 4 |
| Previous | 0 | 5 | 3 | 4 | 1 | 2 | 4 |
Analysts Price Targets
Analyst consensus points towards steady performance with room for value growth, reflected in target price estimates.
| High | Low | Median | Consensus |
|---|---|---|---|
| 130 | 96 | 111 | 112.29 |
Analysts Sentiment
Analyst sentiment remains cautious with a consensus leaning towards a hold, reflecting the need for market watchfulness.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 18 | |
| Hold | 20 | |
| Sell | 3 | |
| Strong Sell | 0 |
Conclusion
Zimmer Biomet Holdings, Inc. stands as a seasoned player in the medical device and orthopedic sector, with stable fundamentals and conservative analyst sentiment. While moderate growth opportunities exist, the company's heavy debt might constrain aggressive expansion efforts. Investors should weigh the potential for steady income against macroeconomic factors that could impact healthcare spending. Keeping an eye on innovation and new product introductions will be crucial for gauging future performance. Overall, Zimmer Biomet presents a cautiously optimistic investment option for risk-tolerant profiles.